Phenestrol information

Phenestrol
Clinical data
Other names	Fenestrol; NSC-183736; hexestrol bis[4-[bis(2-chloroethyl)amino]phenylacetate
Identifiers
	IUPAC name [4-[4-[4-[2-[4-[Bis(2-chloroethyl)amino]phenyl]acetyl]oxyphenyl]hexan-3-yl]phenyl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate;
CAS Number	19659-38-2;
PubChem CID	161290;
ChemSpider	141682;
CompTox Dashboard (EPA)	DTXSID60941425 ;
Chemical and physical data
Formula	C42H48Cl4N2O4
Molar mass	786.66 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCC(C1=CC=C(C=C1)OC(=O)CC2=CC=C(C=C2)N(CCCl)CCCl)C(CC)C3=CC=C(C=C3)OC(=O)CC4=CC=C(C=C4)N(CCCl)CCCl;
	InChI InChI=1S/C42H48Cl4N2O4/c1-3-39(33-9-17-37(18-10-33)51-41(49)29-31-5-13-35(14-6-31)47(25-21-43)26-22-44)40(4-2)34-11-19-38(20-12-34)52-42(50)30-32-7-15-36(16-8-32)48(27-23-45)28-24-46/h5-20,39-40H,3-4,21-30H2,1-2H3; Key:GTWGWCYJKHSRHO-UHFFFAOYSA-N;

Phenestrol, or fenestrol, also known as hexestrol bis[4-[bis(2-chloroethyl)amino]phenylacetate, is a synthetic, nonsteroidal estrogen and cytostatic antineoplastic agent (i.e., chemotherapy drug) and a chlorphenacyl nitrogen mustard ester of hexestrol which was developed in the early 1960s for the treatment of hormone-dependent tumors but was never marketed.^[1]^[2]^[3]^[4]

^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 163–. ISBN 978-1-4757-2085-3.
^ National Cancer Institute (U.S.), Onkologicheskiĭ nauchnyĭ t͡sentr (Akademii͡a medit͡sinskikh nauk SSSR) (1981). Goldin A (ed.). Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. p. 17.
^ Morozova TM, Merkulova TI, Martynov V, Iaguzhinskaia VP, Shkodinskaia EN (1984). "[Properties of alkylating derivatives of estrogens]". Eksperimental'naia Onkologiia (in Russian). 6 (2): 50–54. PMID 6510335.
^ Lagova ND, Sof'ina ZP, Shkodinskaia EN, Kurdiumova KN, Valueva IM (1988). "[The antineoplastic activity of testiphenon]". Voprosy Onkologii (in Russian). 34 (11): 1363–1368. PMID 3201773.

[Elks2014-1] Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 163–. ISBN 978-1-4757-2085-3.

[Goldin(U.S.)1981-2] National Cancer Institute (U.S.), Onkologicheskiĭ nauchnyĭ t͡sentr (Akademii͡a medit͡sinskikh nauk SSSR) (1981). Goldin A (ed.). Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. p. 17.

[pmid6510335-3] Morozova TM, Merkulova TI, Martynov V, Iaguzhinskaia VP, Shkodinskaia EN (1984). "[Properties of alkylating derivatives of estrogens]". Eksperimental'naia Onkologiia (in Russian). 6 (2): 50–54. PMID 6510335.

[pmid3201773-4] Lagova ND, Sof'ina ZP, Shkodinskaia EN, Kurdiumova KN, Valueva IM (1988). "[The antineoplastic activity of testiphenon]". Voprosy Onkologii (in Russian). 34 (11): 1363–1368. PMID 3201773.

Phenestrol information

and 27 Related for: Phenestrol information

Phenestrol

Spironolactone

DDT

Dihydrotestosterone

Steroid

Estrogen

Quercetin

Resveratrol

Testosterone

Dehydroepiandrosterone

Nandrolone

Boldenone undecylenate

Oxymetholone

Rotenone

List of steroids

Apigenin

Nicotinamide

Triclosan

Pharmacokinetics of estradiol

Clomifene

Ethinylestradiol

Testosterone propionate

Testosterone enanthate

Testosterone undecanoate

Tamoxifen

Estradiol valerate

Atrazine